Quick Takeaways
- Michael Powell has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Michael Powell and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | Director | 09 Jun 2025 | |||
| CMPI | Checkmate Pharmaceuticals, Inc. | Director | 31 May 2022 | |||
| GRTX | Galera Therapeutics, Inc. | Director | 14 Jun 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|